New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 27, 2014
15:12 EDTHSP, FMS, DANOY, NSRGY Hospira in talks to acquire Danone medical nutrition business, FT says
French consumer company Danone (DANOY) has been in negotiations to sell its medical nutrition business to Hospira (HSP) in a deal said to value the unit at $5B, says the Financial Times. The deal would also allow for U.S. based Hospira to domicile its tax base in Europe in a tax strategy known as an inversion, added the Financial Times. In prior reports, Nestle (NSRGY) and Fresenius (FMS) have also been mentioned as suitors for the Danone unit. Reference Link
News For DANOY;HSP;NSRGY;FMS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
05:43 EDTHSPHospira announces new white paper extrapolation
Hospira announced the publication of a pivotal white paper titled, "Why extrapolation is paramount to achieving the full promise of biosimilars." The white paper highlights the significance of extrapolation in the development of a successful and sustainable biosimilars market. Real-world cost savings and increased patient access to life-saving medicines can be achieved by conducting only scientifically necessary clinical trials, it states, while also calling for more regulatory agencies to adopt the principle of extrapolation. In the white paper, Ramachandra notes that the scientific principle for extrapolation has already been adopted by the European Medicines Agency, or EMA, and that the European Commission, or EC, has approved 21 biosimilar medicines in Europe, including the first biosimilar monoclonal antibody, Inflectra, in September 2013. In addition, the FDA utilized extrapolation to approve the first biosimilar in the United States, biosimilar filgrastim, last month for all the therapeutic indications of the reference product that were available at that time.
April 23, 2015
12:35 EDTDANOYEarnings Watch: Starbucks sees Q2 EPS 32c-33c on split-adjusted basis
Starbucks (SBUX) is scheduled to report second quarter results after the market close on Thursday, April 23, with a conference call scheduled for 5:00 pm ET. Starbucks purchases and roasts whole bean coffees and sells them, along with brewed coffees, Italian-style espresso beverages, cold blended beverages, food items, teas, and beverage-related accessories and equipment, primarily through company-operated retail stores. EXPECTATIONS: Analysts are looking for earnings per share of 33c on revenue of $4.53B, according to First Call. The consensus range for EPS is 31c-35c on revenue of $4.39B-$4.6B. LAST QUARTER: Starbucks reported first quarter EPS of 80c on revenue of $4.8B, in-line with analysts' estimates, respectively. Starbucks said global comparable store sales increased 5%, with a 2% increase in traffic. The company said comparable store transactions increased by nearly 9M in the U.S. and nearly 12M globally, year-over-year. In conjunction with its earnings release, Starbucks announced the appointment of Kevin Johnson as president and Chief Operating Officer. NEWS: At the company's Annual Meeting of Shareholders in March, the company announced a two-for-one stock split. On a split-adjusted basis, the company revised its Q2 EPS view to 32c-33c to account for the planned stock split; previous Q2 EPS guidance was 64c-65c. The company also revised its EPS guidance for fiscal year 2015 to $1.55-$1.57, which compares to analysts' estimates of $1.57; the company's pre-split FY15 EPS view was $3.09-$3.13. At the meeting, Starbucks announced two delivery models, including a collaboration with Postmates, which will allow customers to order their food and beverage items via the Starbucks mobile app, and a "Green Apron" barista delivery option enabling customers within specified office-buildings to order food and beverages for delivery. Starbucks also reaffirmed its goal to grow its market capitalization to $100B and announced an agreement with Chinese food and beverage producer Tingyi Holding to manufacture and expand the distribution of Starbucks ready-to-drink products throughout mainland China. During the quarter, Evolution Fresh, a unit of Starbucks, and Dannon (DANOY) said they would launch co-branded yogurt products. They said they planned to launch Evolution Fresh Smoothies in 4,300 Starbucks stores in the Pacific Northwest, Northern California and in select Starbucks locations within grocery stores nationwide. Starbucks raised suspicions among European regulators and local governments by reporting losses despite hundreds of millions of dollars in annual sales, The Wall Street Journal reported in early April. STREET RESEARCH: BMO Capital recently initiated Starbucks with an Outperform rating, citing what it sees as the company's many growth opportunities. Shares were also recently initiated at Guggenheim with a Buy rating and $56 target and with an Outperform rating and $56 target at Cowen. Goldman said Starbucks is its top pick in the sector and expects an in-line earnings report. Additionally, the firm expects Starbucks to comment on mobile ordering and the potential for traffic acceleration in the back half of the year and into 2016. Piper Jaffray raised its split-adjusted price target for shares of Starbucks to $55 from $53, which implies 16% upside from current levels. Piper's five-year model suggests the company's earnings double. The firm has an Overweight rating on the stock. Bernstein increased its price target on Starbucks as the firm estimates that falling coffee prices will add at least 3c-4c to the company's fiscal 2016 EPS. PRICE ACTION: Ahead of Thursday afternoon's earnings report, shares are up about 1.2% to $48.93.
April 22, 2015
07:07 EDTFMSEuropean Association for the Study of the Liver to hold annual meeting
50th Annual Meeting of EASL will be held in Vienna, Austria on April 22-26.
April 20, 2015
07:02 EDTHSPEagle Pharmaceuticals price target raised to $75 from $55 at Piper Jaffray
Subscribe for More Information
April 17, 2015
05:32 EDTNSRGYNestle confirms FY15 organic growth outlook of around 5%
Subscribe for More Information
05:29 EDTNSRGYNestle reports three-month organic growth of 4.4%, 1.9% real internal growth
Subscribe for More Information
April 16, 2015
11:44 EDTNSRGYNestle continues to streamline its business as competition heats up, WSJ says
Subscribe for More Information
April 15, 2015
10:24 EDTDANOYDanone sees economic conditions remaining difficult, unstable
Subscribe for More Information
10:23 EDTDANOYDanone reports Q1 reported consolidated sales EUR5.47B
Subscribe for More Information
07:41 EDTHSP, FMSEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
April 14, 2015
06:51 EDTNSRGYNestle in advanced talks to sell Davigel unit to Brakes Group, Reuters reports
Nestle is in advanced discussions for the sale of its Davigel frozen food group to Bain Capital's Brakes Group, Reuters reports, citing a source. A second source says the sale of the deal, which is being handled by Credit Suisse, could raise EUR200M-EUR300M. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use